FENNEC PHARMACEUTICALS INC. Cash
FENNEC PHARMACEUTICALS INC. (FENC) had Cash of $51.18 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Assets
us-gaap:Cash · last filed 2024-05-14
- 2023-03-31: Cash 1.03M CAD.
- 2022-12-31: Cash 34.00K CAD.
- 2022-06-30: Cash 37.00K CAD.
- 2022-03-31: Cash 39.00K CAD.
CAD
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2023-03-31 | 1.03M CAD 10-Q · filed 2023-05-12 | |
| 2022-12-31 | 34.00K CAD 10-Q · filed 2023-05-12 | |
| 2022-06-30 | 37.00K CAD 10-Q · filed 2022-08-12 | |
| 2022-03-31 | 39.00K CAD 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 34.00K CAD 10-Q · filed 2022-08-12 | |
| 2021-09-30 | 37.00K CAD 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 6.00K CAD 10-Q · filed 2021-08-10 | |
| 2021-03-31 | 34.00K CAD 10-Q · filed 2021-05-13 | |
| 2020-12-31 | 34.00M CAD 10-K · filed 2022-02-28 | 45.00M CAD 10-K · filed 2021-03-30 |
| 2020-09-30 | 11.00K CAD 10-Q · filed 2020-11-16 | |
| 2020-06-30 | 34.00K CAD 10-Q · filed 2020-08-05 | |
| 2020-03-31 | 12.00K CAD 10-Q · filed 2020-05-14 | |
| 2019-12-31 | 45.00M CAD 10-K · filed 2022-02-28 | 30.00M CAD 10-K · filed 2020-02-14 |
| 2019-09-30 | 39.00K CAD 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 74.00K CAD 10-Q · filed 2019-08-09 | |
| 2019-03-31 | 110.00K CAD 10-Q · filed 2019-05-10 | |
| 2018-12-31 | 121.00M CAD 10-K · filed 2020-02-14 | |
| 2018-09-30 | 914.00K CAD 10-Q · filed 2018-11-13 | |
| 2018-06-30 | 80.00K CAD 10-Q · filed 2019-08-09 | 6.03M CAD 10-Q · filed 2018-08-13 |
| 2018-03-31 | 141.00K CAD 10-Q · filed 2019-05-10 | |
| 2017-12-31 | 255.00M CAD 10-K · filed 2019-03-15 | 275.00K CAD 10-K · filed 2018-03-28 |
| 2017-09-30 | 282.00K CAD 10-Q · filed 2017-11-13 | |
| 2017-06-30 | 67.00K CAD 10-Q · filed 2017-08-14 | |
| 2017-03-31 | 83.00K CAD 10-Q · filed 2017-05-12 | |
| 2016-12-31 | 68.00K CAD 10-K · filed 2017-03-29 | |
| 2016-09-30 | 156.00K CAD 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 231.00K CAD 10-Q · filed 2016-08-12 | |
| 2016-03-31 | 116.00K CAD 10-Q · filed 2016-05-12 | |
| 2015-12-31 | 25.00K CAD 10-K · filed 2016-03-28 | |
| 2015-09-30 | 49.00K CAD 10-Q · filed 2015-11-12 | |
| 2015-06-30 | 71.00K CAD 10-Q · filed 2015-08-11 | |
| 2015-03-31 | 48.00K CAD 10-Q · filed 2015-05-15 | |
| 2014-12-31 | 53.00K CAD 10-K · filed 2015-03-31 | |
| 2014-09-30 | 24.00K CAD 10-Q · filed 2014-11-13 | |
| 2014-06-30 | 39.00K CAD 10-Q · filed 2014-08-11 | |
| 2014-03-31 | 2.00K CAD 10-Q · filed 2014-05-15 | |
| 2013-12-31 | 39.00K CAD 10-Q · filed 2014-11-13 | |
| 2013-09-30 | 135.00K CAD 10-Q · filed 2013-11-18 | |
| 2013-06-30 | 13.00 CAD 10-Q · filed 2013-08-09 | |
| 2013-03-31 | 31.00K CAD 10-Q · filed 2013-05-13 | |
| 2012-09-30 | 11.00K CAD 10-Q · filed 2012-11-14 | |
| 2012-06-30 | 4.00K CAD 10-Q · filed 2012-08-13 |
USD
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2024-03-31 | $51.18M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $13.27M 10-Q · filed 2024-05-14 | |
| 2023-09-30 | $2.01M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $3.50M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $5.69M 10-Q · filed 2023-05-12 | |
| 2022-09-30 | $29.75M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $278.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $131.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $307.00K 10-K · filed 2024-03-29 | $21.10M 10-Q · filed 2022-11-14 |
| 2021-09-30 | $428.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $398.00K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $26.75M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $8.00K 10-K · filed 2023-03-29 | $678.00M 10-K · filed 2021-03-30 |
| 2020-09-30 | $19.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $604.00K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $382.00K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $678.00M 10-K · filed 2022-02-28 | $347.00M 10-K · filed 2020-02-14 |
| 2019-09-30 | $104.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $135.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $301.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $30.00K 10-Q · filed 2020-05-14 | $770.00M 10-K · filed 2019-03-15 |
| 2018-09-30 | $31.00K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $6.03M 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $5.79M 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $275.00M 10-K · filed 2019-03-15 | $255.00K 10-K · filed 2018-03-28 |
| 2017-09-30 | $440.00K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $127.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $3.00K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $51.00K 10-Q · filed 2017-11-13 | |
| 2016-09-30 | $66.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $94.00K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $57.00K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $11.00K 10-Q · filed 2016-11-14 | $12.00K 10-K · filed 2016-03-28 |
| 2015-09-30 | $13.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $69.00K 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $37.00K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $100.00K 10-K · filed 2015-03-31 | |
| 2014-09-30 | $94.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $39.00K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $5.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $1.66M 10-K · filed 2015-03-31 | $28.00K 10-Q · filed 2014-05-15 |
| 2013-09-30 | $277.00K 10-Q · filed 2013-11-18 | |
| 2013-06-30 | $94.00 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $22.00K 10-Q · filed 2013-05-13 | |
| 2012-09-30 | $150.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $113.00K 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |